We’re extending a big Boundless welcome to our 2024 summer interns, Anjali Bose, Jackson Bishop, Wanyi Zhu, Katia Garcia, Abeni Thomas and Rand Ato! Last week they joined us for a welcome outing to Torrey Pines State Beach to kick off the summer together. These stellar individuals will work closely with various R&D and business teams to gain firsthand experience from BoundTowners. We are looking forward to all their contributions this summer as we work together to develop novel therapies for patients with oncogene amplified cancer!
Boundless Bio
Biotechnology Research
San Diego, California 6,345 followers
Unbound by convention, bound to save lives
About us
Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence. When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes, driving cancer cells to grow and allowing them to resist treatment. At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive. Our Culture: At Boundless, you’ll experience what it means to be out in front of the wave. Our unprecedented science takes us to new shores, and our team navigates the best breaks. We’re leaders in our field, and we’re dedicated to the cause of understanding and treating intractable cancers. Every employee at Boundless makes an unbridled impact on our capabilities and our culture. We’ll help you expand your abilities and defy your bounds by providing meaningful work and unbounded opportunities. Career development is essential at Boundless. We’re all in on this fight against cancer– collaboration is requisite to our success. We have a team of people who ask, offer, and accept help without regard for ego. We know that receiving support is energizing, and giving help is fulfilling. We are inspired by the patients who are reliant upon our success. At Boundless, we’re all in. We are unbound by convention, bound to save lives. Career Inquiries careers@boundlessbio.com General Information Inquiries info@boundlessbio.com
- Website
-
http://www.boundlessbio.com
External link for Boundless Bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Diego, California
- Type
- Privately Held
Locations
-
Primary
9880 Campus Point Dr
San Diego, California 92121, US
Employees at Boundless Bio
Updates
-
It was a pleasure to kick off our Summer of Service with the 2nd annual Life Science Cares San Diego "Feeding Bodies, Fueling Minds" Summer Food Drive. Our BoundTowners stepped up, bringing needed food items in for this worthy cause and volunteering to help Feeding San Diego provide meals to students experiencing food insecurity.
What a fantastic day in the life science industry! Today was the 2nd annual Life Science Cares "Feeding Bodies, Fueling Minds" Summer Food Drive! 25 life science companies came together today to donate food and volunteer at Feeding San Diego! Nearly 50% of students in San Diego County rely on free or reduced-price meals provided in schools. During the summer these meals are unavailable. To address this, our goal was to provide 10,000 meals to students experiencing food insecurity this summer. There is still time to donate to our fundraiser to get $ directly to Feeding San Diego to provide food for students in need. https://lnkd.in/gyYtXYpm HUGE THANK YOU! To all of the companies who participated in this years drive! Check back next week for an update on how many meals we all provided together! Together we can do more! Thank you to: 858 Therapeutics, Alexandria Real Estate Equities, Inc. Alterome Therapeutics, Inc. AnaptysBio, aTyr Pharma BioAtla, Inc. Biocom California Boundless Bio, Cellics Therapeutics, Inc. Christopher Weil & Company, Inc. Equillium, Inc. Erasca, Inc. Gossamer Bio Halloran Consulting Group, Inc. Heron Therapeutics, Inc. Illumina Inception Therapeutics Insmed Incorporated Kumquat Biosciences Inc. Light Horse Therapeutics MEI Pharma Neurelis, Inc. Nighthawk Pfizer Sorriso Pharmaceuticals
-
-
-
-
-
+7
-
-
Boundless Bio reposted this
Great discussion on new challenges and opportunities in navigating partnerships across borders with Takeda, Boundless Bio, Caszyme, Fosun Pharma and Retroviral Therapeutics
-
-
We’re pleased to be at the Longwood Healthcare Leaders’ Spring 2024 MIT meeting next week where our Chief Business Officer, Neil Abdollahian, will moderate the panel “Navigating Partnerships Across Borders." Neil will facilitate a conversation on threading partnerships across geographies with experienced industry leaders. Register and join us: https://lnkd.in/exxKDits
-
-
Bump, set, spike. The first 2024 Boundless Bio sport tournament was a huge hit last week as teams of BoundTowners took to the courts to play it out in volleyball! Teammates had a blast competing for the top spot and tackling a new kind of teamwork together. 🏐 📸: Group photo by Julius Apuy
-
-
We're at #BIO2024 connecting with industry and partners. Chief Financial Officer, Jami Rubin, had a fireside chat with Endpoints News’ Executive Editor Drew Armstrong Monday morning to kick off the week, offering insights from her long career in biopharma.
-
-
We’ll be at the Goldman Sachs 45th Annual Global #Healthcare Conference next week, where our President and Chief Executive Officer, Zachary Hornby, and Chief Financial Officer, Jami Rubin, will take the stage for a fireside chat. Learn more about the event: https://lnkd.in/e7Hy6EA5 Watch live: https://lnkd.in/ePYWJnDf
-
#BIO2024 is fast approaching and we’re excited to see our Chief Financial Officer, Jami Rubin, sit down with Endpoints News’ Executive Editor Drew Armstrong on Monday to discuss her multi-decade Wall Street career, her journey to our IPO, $BOLD, and deep expertise in biopharma. Learn more and join us: https://lnkd.in/gGh4t8G7
-
-
For the first time as a public company, we're excited to announce our financial results for the first quarter of 2024 and highlight recent progress, including initiation of targeted therapy combinations in our ongoing Phase 1/2 POTENTIATE clinical trial of BBI-355, the first patient dosed in the Phase 1/2 STARMAP study of BBI-825 in patients with resistance gene amplifications, and the completion of our recent IPO. Read more: https://lnkd.in/gskw__rK
-
-
Boundless Bio reposted this
Last year, our summer #FoodDrive event brought the life science industry together to provide 7,738 meals to food-insecure students throughout San Diego! As we kick off this year’s food drive, we look forward to giving back to our community again as we strive to provide 10,000 meals to students in need. 🥑 🥕 🥖 On Friday, June 14, we’ll partner with Feeding San Diego for our annual community-wide Food Drive event aimed at addressing the summer meal gap that exists when local students do not have access to meals provided in school. 📣 Life Science companies in San Diego are invited to join our food drive! Please like and share this post to amplify! 📣 Be sure to register for the event before the May 24 deadline: https://lnkd.in/gn-xgJWp Thank you to our partners who have already signed up! Alexandria Real Estate Equities, Inc. aTyr Pharma Boundless Bio Cellics Therapeutics, Inc. Biocom California Erasca, Inc. Neurelis, Inc. Illumina #FeedingBodiesFuelingMinds
-